No Data
Assessing Guardant Health: Insights From 7 Financial Analysts
In the latest quarter, 7 analysts provided ratings for Guardant Health (NASDAQ:GH), showcasing a mix of bullish and bearish perspectives.The table below summarizes their recent ratings, showcasing
Express News | Goldman Sachs Maintains Buy on Guardant Health, Raises Price Target to $32
Express News | Guardant Health Inc : TD Cowen Raises Target Price to $41 From $37
Express News | Guardant Health Inc : TD Cowen Raises Target Price to $42 From $37
Is Guardant Health (NASDAQ:GH) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we
Top Premarket Gainers
African Agriculture (AAGR) shares surged nearly 72% in recent Friday premarket activity, shaving Thursday's 3% loss. Cosmos Health (COSM) stock was almost 59% higher after the company said Thursday it